BBGI Plc, the biotechnology arm of Bangchak Corporation Plc, remains confident about its business expansion plan, supported by ongoing fundraising under the company's initial public offering (IPO) programme that began yesterday.
BBGI Plc, the biotechnology arm of Bangchak Corporation Plc (BCP), expects its earnings from new businesses, especially healthcare solutions, to make up half of total gross profit within a period of five years.